Chai Discovery

Chai DiscoveryChai Discovery
Chai Discovery

Chai Discovery

AI-powered drug discovery platform using foundation models for molecular design.

DR 652023ActiveSan Francisco, United States
Rate

About

Chai Discovery, founded in 2024 (OpenAI-backed, incubated in OpenAI offices), builds foundation models for predicting biochemical interactions. Raised $130M Series B at $1.3B valuation (Dec 2025). Partnership with Eli Lilly for drug development.
Frequently asked

What does Chai Discovery do?

Chai Discovery, founded in 2024 (OpenAI-backed, incubated in OpenAI offices), builds foundation models for predicting biochemical interactions. Raised $130M Series B at $1.3B valuation (Dec 2025). Partnership with Eli Lilly for drug development.

What is Chai Discovery's revenue?

StartupHub estimates Chai Discovery's annual revenue at $644.1M (range $422.2M to $678.6M, 42% confidence), based on comparable companies in the sector.

What is Chai Discovery's valuation?

StartupHub estimates Chai Discovery's effective valuation at $3.9B (range $2.7B to $5.1B, 41% confidence), based on comparable companies in the sector.

How much funding has Chai Discovery raised?

Chai Discovery has raised a total of $872M in funding. The most recent round on record is Series C.

Where is Chai Discovery headquartered?

Chai Discovery is headquartered in San Francisco, United States.

When was Chai Discovery founded?

Chai Discovery was founded in 2023.

What industry does Chai Discovery operate in?

Chai Discovery operates in Artificial Intelligence, Biotechnology, Drug Discovery, Molecular Design, Foundation Models, NeoLab.

Comments

No comments yet. Be the first to share your take.